Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome - Wikidata - wikimedia - TriplyDB

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

http://www.wikidata.org/entity/Q33681857

about

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 Broadly Neutralizing Antibodies for HIV Eradication Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex.Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology.Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Discovery of antibodies Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.Strategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.Clinical experience with therapeutic AIDS vaccines.Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.Passive immunity in the prevention of maternal-fetal transmission of human immunodeficiency virus infection.Immunotherapy for infectious diseases.Postconditioning hormesis put in perspective: an overview of experimental and clinical studies.High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors.

P2860

Q24560010-5A7D12EB-1309-4B4D-B3B9-3D6D8B64E47B Q27469855-DEBDF949-6CC4-4E16-8CA1-16D7AB02B14F Q28073939-68ECCD63-93BD-413B-B1EC-D3D5518B145F Q33377921-30292AB9-A6D8-4ABB-B064-3BD101EDAB5A Q33778686-D8345B57-C6A6-488D-AEB9-694E3CD86B53 Q33822379-F949ED95-3054-466F-94FC-231549B3CEE5 Q33880904-96E4482D-FB7C-4426-A0BF-ADCACCE1295C Q34097650-5D938D63-ADC7-4946-A5BD-4FEA9B00E41B Q34389695-8C827E2F-901B-4805-B654-4B412935CF1A Q34702647-F2413736-6B3F-4F3C-95C1-BD58B748F052 Q35137276-47D1CA99-D3B8-46F9-8CBE-62724AF0BBA8 Q35211596-39B1FA96-789E-4A43-B2B1-81849ADD8DFD Q35325810-DBF45C61-8E55-4512-ACCF-43C1281ECCF2 Q35653539-CBDD50C7-7D91-466D-A9A1-2E244B22348F Q35894716-BC4B068F-FDD3-4CB7-B8B7-7CAD99D48B96 Q35930774-F7D4BBC3-F2A3-498C-8F4F-0EE70FEC2605 Q36198648-41AA619F-A090-47E7-A5D9-2095BDE36FF4 Q36353458-25E64B6F-4366-4F92-88B2-4063014D9545 Q36690500-1193E372-668E-43E9-AE8F-60600F313377 Q36908469-0DECA774-41C0-4579-B006-BECA26D41ED2 Q38310881-3565ED6E-F525-4367-ACF7-E4B278B83244 Q40643799-449C8440-35B6-4CDC-8148-4FE87F3467D7 Q41168545-206EF960-BAFD-4F8E-B92A-3A5D74DA7100 Q42764966-ACE6C1E7-4B3F-4E00-A51F-5B7D193C9911 Q44740759-D649809D-6F24-4C13-8628-8FC35CAA3436

P2860

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

http://www.wikidata.org/entity/Q33681857

description

1988 nî lūn-bûn

@nan

1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@ast

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@en

type

label

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@ast

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@en

prefLabel

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@ast

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@en

P1433

Q33681857-7D3A1E07-CD0D-44D4-BF10-76276533AEA1

P1476

Q33681857-8A566A9D-8505-4E5C-B154-A5148163C6DE

P2093

Q33681857-20E3C3D4-5442-409E-94C8-F9B2888B3D25

Q33681857-64CF9BEF-7BCC-4C55-86C7-CCEE7A866DB5

Q33681857-7B1F0F27-2190-449A-8B9F-DD1B6955D077

Q33681857-829AE7BE-669E-48C2-A8F5-2A751969E26B

Q33681857-972DCD9B-579D-4745-92D3-51D880D38044

Q33681857-C7E751CD-CE9D-4BC6-9DF7-24764F808D61

Q33681857-CDF5E7FD-FF17-4038-A487-1488BAB34343

Q33681857-DE5FF62B-D3F2-4E18-9B4E-D9F8C4C7AFCD

Q33681857-E455120D-8033-4D1F-8FAD-8134B9377E0D

Q33681857-EFDB57E0-1144-483A-8DCA-7FBFF6A9016E

P2860

Q33681857-0269E469-6DA9-4F77-9582-43AE2A8EB7E2

Q33681857-13B61EBA-0C99-40F1-AC7C-A8951B121B68

Q33681857-2321901A-4AB8-4BD7-9F65-41C673E78854

Q33681857-2DC6ABCD-E076-4141-A7A3-6E48279A8D3B

Q33681857-469F3CF7-194E-4C71-A8EE-BF02799AE946

Q33681857-5C6F44CD-02F8-4F0F-BAA1-CF96936A9D03

Q33681857-65883A4F-47CC-493B-A394-D81612641864

Q33681857-81DF3A96-4DF1-46CB-943F-F363BB696843

Q33681857-92C3B893-E18F-4978-BFDF-D74B1294C10E

Q33681857-C561353B-C627-4A74-81C3-E61EA1AFEE28

P304

Q33681857-DDFBD1AE-0B5A-46B8-B25C-6CDFA9850315

P31

Q33681857-12E6333A-429A-44E8-88A6-A2B8A9D1FFB8

P356

Q33681857-F2D41915-3CF4-4E59-9231-F117F7648950

P407

Q33681857-86073D8F-7D1F-4967-824F-244265ADE7B1

P433

Q33681857-57220A1E-F39A-41AA-8F3A-4FACD8771165

P478

Q33681857-D16396B8-18BC-4A32-B12D-C51893A67FEF

P577

Q33681857-F30040DC-6277-42C8-805E-992504E27E6F

P5875

Q33681857-94B9D660-4AFB-487A-974B-9D56047EC504

P698

Q33681857-99284543-9402-4B69-8674-8611D34A5578

P921

Q33681857-4B45E009-F287-4BEF-A847-A8574C376F6C

P932

Q33681857-58406260-2301-4FB1-A617-564FD7A592F6

P356

PNAS.85.23.9234

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Effects of passive immunizatio ...... ired immunodeficiency syndrome

@en

P2093

Byron N

http://www.w3.org/2001/XMLSchema#string

Cullen V

http://www.w3.org/2001/XMLSchema#string

Gilgen D

http://www.w3.org/2001/XMLSchema#string

Gray J

http://www.w3.org/2001/XMLSchema#string

Hayhoe F

http://www.w3.org/2001/XMLSchema#string

Hill F

http://www.w3.org/2001/XMLSchema#string

Howard L

http://www.w3.org/2001/XMLSchema#string

Karpas A

http://www.w3.org/2001/XMLSchema#string

Tenant-Flowers M

http://www.w3.org/2001/XMLSchema#string

Youle M

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Isolation of a new human retrovirus from West African patients with AIDS.

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Restriction of sensitivity of HIV-1-antigen ELISA by serum anti-core antibodies.

Unusual virus produced by cultured cells from a patient with AIDS.

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.

Use of Karpas HIV cell test to detect antibodies to HIV-2.

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

HIV antigenaemia and virus isolation from plasma during primary HIV infection.

Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies.

P304

9234-9237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.23.9234

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19962718

http://www.w3.org/2001/XMLSchema#string

P698

3194422

http://www.w3.org/2001/XMLSchema#string

P921

P932

282713

http://www.w3.org/2001/XMLSchema#string